Back
Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings
Sponsored
BCYC
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
45
BCYC
Bicycle Therapeutics PLC
Last Price:
22.77
Seasonality Move:
18.6%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Bicycle Therapeutics PLC Price Quote
$22.77
+0.04 (+1.11%)
(Updated: April 27, 2024 at 4:26 AM ET)
Bicycle Therapeutics PLC Key Stats
Sell
45
Bicycle Therapeutics PLC (BCYC)
is a Sell
Day range:
$22.52 - $23.54
52-week range:
$12.54 - $28.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.97
P/B ratio:
2.32%
Volume:
143.7K
Avg. volume:
409.4K
1-year change:
13.71%
Market cap:
$861M
Revenue:
$27M
EPS:
$-5.13
How Much Does Bicycle Therapeutics PLC Make?
-
How Much Are Bicycle Therapeutics PLC's Sales Annually?
BCYC Revenues are $27M -
How Much Profit Does Bicycle Therapeutics PLC's Make A Year?
BCYC net income is -$180.7M
Is Bicycle Therapeutics PLC Growing As A Company?
-
What Is Bicycle Therapeutics PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.67% -
What Is Bicycle Therapeutics PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Bicycle Therapeutics PLC Stock Price Performance
-
Did Bicycle Therapeutics PLC Stock Go Up Last Month?
Bicycle Therapeutics PLC share price went down by -7.34% last month -
Did BCYC's Share Price Rise Over The Last Year?
BCYC share price rose by 13.71% over the past 1 year
What Is Bicycle Therapeutics PLC 52-Week High & Low?
-
What Is Bicycle Therapeutics PLC’s 52-Week High Share Price?
Bicycle Therapeutics PLC has traded as high as $28.91 over the past 52 weeks -
What Is Bicycle Therapeutics PLC’s 52-Week Low Share Price?
Bicycle Therapeutics PLC has traded as low as $12.54 over the past 52 weeks
Bicycle Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bicycle Therapeutics PLC?
-
How Much Debt Does Bicycle Therapeutics PLC Have?
Total long term debt quarterly is $30.7M -
How Much Cash Does Bicycle Therapeutics PLC Have?
Cash and short term investments quarterly total is $526.4M -
What Is Bicycle Therapeutics PLC’s Book Value Per Share?
Book value per share is 9.83
Is Bicycle Therapeutics PLC Cash Flow Positive?
-
What Is BCYC Cash Flow From Operations?
Cash flow from operations (TTM) is -$60.6M -
What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $250M -
What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.9M
Bicycle Therapeutics PLC Return On Invested Capital
-
Is Management Doing A Good Job?
BCYC return on invested capital is -53.98% -
What Is Bicycle Therapeutics PLC Return On Assets?
ROA measures how assets are converting to revenues and is -35.74% -
What Is BCYC Return On Equity?
ROE is a measure of profitability and is -59.39%
Bicycle Therapeutics PLC Earnings Date & Stock Price
-
What Is Bicycle Therapeutics PLC's Stock Price Today?
A single share of BCYC can be purchased today for 22.73 -
What Is Bicycle Therapeutics PLC’s Stock Symbol?
Bicycle Therapeutics PLC trades on the nasdaq under the ticker symbol: BCYC -
When Is Bicycle Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Bicycle Therapeutics PLC is scheduled on May 3, 2024 -
When Is BCYC's next ex-dividend date?
Bicycle Therapeutics PLC's next ex-dividend date is April 27, 2024 -
How To Buy Bicycle Therapeutics PLC Stock?
You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bicycle Therapeutics PLC Competitors
-
Who Are Bicycle Therapeutics PLC's Competitors?
Below is a list of companies who compete with Bicycle Therapeutics PLC or are related in some way:
Bicycle Therapeutics PLC Dividend Yield
Data Unavailable
Bicycle Therapeutics PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 2.75% |
Revenue: | 67.38% | -22.48% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 43.99 |
Upside from Last Price: | 93.52% |